MOG Antibodies

Santa Cruz Biotechnology features a diverse variety of MOG Antibodies for advanced research in neuroscience and immunology. MOG Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Myelin oligodendrocyte glycoprotein (MOG) is a critical component of the myelin sheath in the central nervous system, playing a vital role in maintenance and stability of myelin. MOG has been identified as a key factor in autoimmune diseases, such as multiple sclerosis, making MOG research essential for studying demyelination and neuroinflammation. Understanding MOG function provides valuable insights for developing therapeutic strategies targeting demyelinating conditions. Research focusing on MOG has revealed significant implications for treating neurological disorders. Investigating MOG expression patterns helps illuminate mechanisms of disease progression and potential intervention points. Current studies utilizing MOG monoclonal antibodies continue advancing our understanding of myelin biology and neurodegenerative processes. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific knowledge of neurological conditions and potential therapeutic approaches.